Taisho Pharmaceutical Holdings Co (TSE:4581) Market Cap : 円695,676 Mil (As of Apr. 29, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Taisho Pharmaceutical Holdings Co's share price for the quarter that ended in Dec. 2023 was 円233649000000. Taisho Pharmaceutical Holdings Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 82 Mil. Therefore, Taisho Pharmaceutical Holdings Co's market cap for the quarter that ended in Dec. 2023 was 円19,183,751,145,000 Mil.

Taisho Pharmaceutical Holdings Co's quarterly market cap increased from Jun. 2023 (円12,015,877,264,000 Mil) to Sep. 2023 (円13,672,068,008,000 Mil) and increased from Sep. 2023 (円13,672,068,008,000 Mil) to Dec. 2023 (円19,183,751,145,000 Mil).

Taisho Pharmaceutical Holdings Co's annual market cap declined from Mar. 2021 (円15,421,244,322,000 Mil) to Mar. 2022 (円12,517,378,046,000 Mil) and declined from Mar. 2022 (円12,517,378,046,000 Mil) to Mar. 2023 (円12,246,179,065,000 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Taisho Pharmaceutical Holdings Co's Enterprise Value for Today is 円429,309 Mil.

Taisho Pharmaceutical Holdings Co Market Cap Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Market Cap Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Market Cap

Get a 7-Day Free Trial

22,780,575,690,000.00

14,340,209,772,000.00

15,421,244,322,000.00

12,517,378,046,000.00

12,246,179,065,000.00

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															12,869,906,457,000.00	12,246,029,876,000.00	12,015,877,264,000.00	13,672,068,008,000.00	19,183,751,145,000.00

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taisho Pharmaceutical Holdings Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Market Cap falls into.

Taisho Pharmaceutical Holdings Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Taisho Pharmaceutical Holdings Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )	=	Share Price (A: Mar. 2023 )	*	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	円149189000000	*	82.085
	=	円12,246,179,065,000

Taisho Pharmaceutical Holdings Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	円233649000000	*	82.105
	=	円19,183,751,145,000

Taisho Pharmaceutical Holdings Co (TSE:4581) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Taisho Pharmaceutical Holdings Co Market Cap Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines